The Benefit of a Cardiac Rehabilitation Programme on Cardiovascular and Exercise Parameters in Patients with Type 2 Diabetes Mellitus: The First Study Among the Iranian Population
M. Nejatian, Manijeh Zarghampou, A. Karimi, M. Sheikhvatan
{"title":"The Benefit of a Cardiac Rehabilitation Programme on Cardiovascular and Exercise Parameters in Patients with Type 2 Diabetes Mellitus: The First Study Among the Iranian Population","authors":"M. Nejatian, Manijeh Zarghampou, A. Karimi, M. Sheikhvatan","doi":"10.5083/EJCM.20424884.29","DOIUrl":null,"url":null,"abstract":"Diabetes mellitus is a common risk profile and quality-of-life damaging factor in patients with acute coronary syndrome (ACS) and an important leading cause of mortality and morbidity in these patients. According to the American Diabetes Association report, although the prevalence of diabetes mellitus among general population was estimated at less than 9%, this estimated prevalence in ACS patients is considerably higher (1-3).","PeriodicalId":75000,"journal":{"name":"The European journal of cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2011-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5083/EJCM.20424884.29","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The European journal of cardiovascular medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5083/EJCM.20424884.29","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Diabetes mellitus is a common risk profile and quality-of-life damaging factor in patients with acute coronary syndrome (ACS) and an important leading cause of mortality and morbidity in these patients. According to the American Diabetes Association report, although the prevalence of diabetes mellitus among general population was estimated at less than 9%, this estimated prevalence in ACS patients is considerably higher (1-3).